CAHP Statement: California Senate Votes on Widely-Supported Drug Price Transparency Bill

The California State Senate Committee on Health is set to vote today on SB 17, which responds to growing concerns over the impacts of drug companies’ efforts to push the limits on prescription drug prices that have left California families and state programs grappling with the realities of six-figure price tags for common medications.

Runaway Rx: Infographic – SB 17: Transparency in Drug Pricing

Runaway Rx: Infographic - SB 17: Transparency in Drug Prici…

Runaway Rx: Bipartisan Support for Drug Price Transparency

Runaway Rx: Bipartisan Support for Drug Price Transparency